C12Y 306/03004
Cu2+-exporting atpase
Official title: Cu2+-exporting ATPase (3.6.3.4)
C12Y306/03004 (Cu2+-exporting atpase) appears on 5 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 10
- Assignees
- 7
- Inventors
- 26
- Latest grant
- 24 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 3 | 3 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders24 Dec 2024US 12,173,306 B2The United States of America, as represented by the Secretary, Dept. of Health and Human Services
- Oligonucleotide therapy for Wilson disease14 Feb 2023US 11,578,327 B2Deep Genomics Incorporated
- Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson disease19 Oct 2021US 11,147,887 B2FundacióN Para La InvestigacióN MéDica Aplicada
- Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson's disease and other conditions14 Sep 2021US 11,118,238 B2FundacióN Para La InvestigacióN MéDica Aplicada
- Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders27 Apr 2021US 10,988,778 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Gene therapy for the treatment of wilson's disease8 May 2025US 2025/0144239 A1LogicBio Therapeutics, Inc.
- Codon-optimized reduced-size atp7a cdna and uses for treatment of copper transport disorders24 Apr 2025US 2025/0129382 A1The United States of America, as represented by the Secretary, Dept. of Health and Human Services
- Nucleic acid constructs and gene therapy vectors for use in the treatment of wilson disease13 Jan 2022US 2022/0008559 A1FundacióN Para La InvestigacióN MéDica Aplicada
- Compositions and methods for treating wilson's disease2 Dec 2021US 2021/0369870 A1Encoded Therapeutics, Inc.
- Codon-optimized reduced-size atp7a cdna and uses for treatment of copper transport disorders15 Jul 2021US 2021/0214751 A1The United States of America, as represented by the Secretary, Dept. of Health and Human Services
Most cited
By later US patents